Nasif Islam

Nasif Islam is Director, Strategy and Business Development at Priovant Therapeutics. Prior to joining Priovant, Nasif was a healthcare investment banker at Credit Suisse, where he advised small- and mid-cap biotech companies on mergers, acquisitions, and financing. Before Credit Suisse, Nasif was a strategy consultant at Trinity Partners, where he worked with a wide range of biotech and pharma companies on corporate strategy, market research, and business development. Nasif holds a Ph.D. in regenerative medicine from The Johns Hopkins University School of Medicine and a BS from Cornell University.